CONDITIONS FOR IMMUNOSUPPRESSION BY RIFAMPICIN

被引：40

作者：

BASSI, L

DIBERNAR.L

ARIOLI, V

SILVESTRI, LG

LIGNIERE, EL

机构：

[1] UNIV PAVIA, CLIN MED, PAVIA, ITALY

[2] GRUPPO LEPETIT SPA, 20158 MILAN, ITALY

来源：

JOURNAL OF INFECTIOUS DISEASES | 1973年 / 128卷 / 06期

关键词：

D O I：

10.1093/infdis/128.6.736

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：736 / 744

页数：9

共 27 条

[1]

ARRIGONI-MARTELLI E, 1971, Pharmacological Research Communications, V3, P239, DOI 10.1016/0031-6989(71)90019-1

[2]

BENEZRA D, 1972, ISRAEL J MED SCI, V8, P987

[3]

BLINKOFF RC, 1966, J IMMUNOL, V97, P736

[4]

BRAUN W, 1972, IMMUNOGENICITY

[5]

DAJANI BM, 1972, LANCET, V2, P1094

[6]

Davis B.D., 1968, MICROBIOLOGY

[7]

FREIDLIN I S, 1972, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, V49, P66

[8]

FURESZ S, 1970, ANTIBIOT CHEMOTHER, V16, P316

[9]

GIALDRONIGRASSI G, 1972, J INFECT DIS, V126, P542

[10] SPECIFIC INHIBITION OF DNA-DIRECTED RNA SYNTHESIS BY RIFAMYCIN [J].

HARTMANN, G ;

HONIKEL, KO ;

KNUSEL, F ;

NUESCH, J .

BIOCHIMICA ET BIOPHYSICA ACTA, 1967, 145 (03) :843-&

← 1 2 3 →